Dendritic cells in allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 8, 1999, Pages 792-803

  Novak, N ^a   Haberstok, J ^a   Geiger, E ^a   Bieber, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Allergy; Asthma; Atopic dermatitis; Dendritic cells; Immunotherapy

Indexed keywords

ANTIGEN; ASCOMYCIN; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; TACROLIMUS;

ALLERGY; ANTIGEN PRESENTATION; ASTHMA; ATOPIC DERMATITIS; ATOPY; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; HUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; RHINITIS; SKIN ALLERGY; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ANTIGENS; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOTHERAPY;

EID: 0032780116     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00101.x     Document Type: Review

References (89)

1. 1. Birbeck MS, Breathnach AS, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 1961;37:51-64.
2. 2. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:1141-1162.
3. 3. Nestle FO, Nickoloff BJ. Dermal dendritic cells are important members of the skin immune system. In: Banchercau J, Schmitt D, editors. Dendritic cells in fundamental and clinical immunology. New York: Plenum Press, 1995:111-116.
4. 4. Caux C. Pathways of development of human dendritic cells. Eur J Dermatol 1998;8:375-384.
5. 5. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979;282:324-326.
6. 6. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-261.
7. 7. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
8. 8. Hashimoto S, Yamada M, Motoyoshi K, Akagawa KS. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 1997;89:315-321.
9. 9. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994;82:487-493.
10. 10. Olweus J, Bit Mansour A, Warnke R, et al. Dendritic cell ontogeny; a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A 1997;94:12551-12556.
11. 11. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
12. 12. Hill S, Griffiths S, Kimber I, Knight SC. Migration of dendritic cells during contact sensitization. Adv Exp Med Biol 1993;329:315-320.
13. 13. Knight SC, Krejci J, Malkovsky M, Colizzi V, Gautam A, Asherson GL. The role of dendritic cells in the initiation of immune responses to contact sensitizers. In vivo exposure to antigen. Cell Immunol 1985;94:427-434.
14. 14. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
15. 15. Inaha K, Steinman RM. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J Exp Med 1987;165:1403-1417.
16. 16. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med 1996;183:1287-1292.
17. 17. Buelens C, Willems F, Delvaux A, et al. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995;25:2668-2672.
18. 18. Schultze JL, Michalak S, Lowne J, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med 1999;189:1-12.
19. 19. van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998;280:243-248.
20. 20. Krasteva M, Kehren J, Horand F, et al. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 1998;160:1181-1190.
21. 21. Krasteva M, Kehren J, Choquet G, Kaiserlian D, Nicolas JF. The role of dendritic cells in contact hypersensitivity [Letter; comment]. Immunol Today 1998;19:289.
22. 22. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-44.
23. 23. Bour H, Peyron E, Gaucherand M, et al. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995;25:3006-3010.
24. 24. Xu H, Di Iulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (TH1) effector CD8+ T cells and interleukin (IL) 4/IL-10-producing (TH2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1001-1012.
25. 25. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992;149:92-95.
26. 26. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993;151:2390-2398.
27. 27. Kelsall BL, Stuber E, Neurath M, Strober W. Interleukin-12 production by dendritic cells. The role of CD40-CD40L-interactions in Th1 T-cell responses. Ann NY Acad Sci 1996;795:116-126.
28. 28. Kennedy MK, Picha KR, Shanebeck KD, Anderson DM, Grabstein KH. Interleukin-12 regulates the proliferation of Th1, but not Th2 or TH0, clones. Eur J Immunol 1994;24:2271-2178.
29. 2, promote Th2 responses. Adv Exp Med Biol 1997;417:363-367.
30. 2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997;159:28-35.
31. 31. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
32. 31. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invent Dermatol 1996;106:446-453.
33. 33. Jurgens M, Wollenberg A, Hanau D, de la Salle H, Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol 1995;155:5184-5189.
34. 34. Kraft S, Wessendorf JH, Hanau D, Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998;161:1000-1006.
35. 35. Bieber T. Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game. Immunol Today 1997;18:311-313.
36. 36. Bieber T. Fc epsilon RI on human epidermal Langerhans cells: an old receptor with new structure and functions. Int Arch Allergy Immunol 1997;113:30-34.
37. 37. Bieber T, Kraft S, Jurgens M, et al. New insights in the structure and biology of the high affinity receptor for IgE (Fc epsilon RI) on human epidermal Langerhans cells. J Dermatol Sci 1996;13:71-75.
38. 38. Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-616.
39. 39. Bieber T. Fc epsilon RI on human Langerhans cells: a receptor in search of new functions. Immunol Today 1994;15:52-53.
40. 40. Bieber T, de la Salle H, de la Salle C, Hanau D, Wollenberg A. Expression of the high-affinity receptor for IgE (Fc epsilon RI) on human Langerhans cells: the end of a dogma. J Invest Dermatol 1992;99:10S-11S.
41. 41. Bieber T. IgE binding molecules on human Langerhans cells. Acta Derm Venereol Suppl (Stockh) 1992;176:54-57.
42. 41. Maurer D, Stingl G. Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J Invest Dermatol 1995;104:707-710.
43. 43. Stingl G, Maurer D. IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. Int Arch Allergy Immunol 1997;113:24-29.
44. 44. Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995;154:6285-6290.
45. 45. Maurer D, Fiebiger E, Reininger B, et al. Fc epsilon receptor I on dendritic tells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol 1998;161:2731-2739.
46. 46. Bonnerot C, Lankar D, Hanau D, et al. Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity 1995;3:335-347.
47. 2 determine the IFN-gamma level of activated human CD4+ T cells. J Immunol 1996;156:1722-1727.
48. 48. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG. CDIa-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy 1989;19:597-601.
49. 49. Bieber T. Are resident Langerhans cells "activated" precursors of lymphoid dendritic cells? [Letter]. Br J Dermatol 1991;125:401.
50. 50. Hellquist HB, Olsen KE, Irander K, Karlsson E, Odkvist LM. Langerhans cells and subsets of lymphocytes in the nasal mucosa. APMIS 1991;99:449-454.
51. 51. McWilliam AS, Nelson DJ, Holt PG. The biology of airway dendritic cells. Immunol Cell Biol 1995;73:405-413.
52. 51. Godthelp T, Fokkens WJ, Kleinjan A, et al. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation. Clin Exp Allergy 1996;26:677-688.
53. 53. Rajakulasingam K, Durham SR, O'Brien F, et al. Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 1997;100:78-86.
54. 54. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (CDIa)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991;173:1345-1356.
55. 55. Jansen HM. The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Allergy 1996;51:279-291.
56. 56. Jacobi HH, Liang Y, Tingsgaard PK, et al. Dendritic mast cells in the human nasal mucosa. Lab Invest 1998;78:1179-1184.
57. 57. Fokkens WJ, Broekhuis-Fluitsma DM, Rijntjes E, Vroom TM, Hoefsmit EC. Langerhans cells in nasal mucosa of patients with grass pollen allergy. Immunobiology 1991;182:135-141.
58. 58. Fokkens WJ, Vroom TM, Gerritsma V, Rijntjes E. A biopsy method to obtain high quality specimens of nasal mucosa. Rhinology 1988;26:293-295.
59. 59. Fokkens WJ, Vroom TM, Rijntjes E, Mulder PG. Fluctuation of the number of CD-1(T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season. J Allergy Clin Immunol 1989;84:39-43.
60. 60. Fokkens WJ, Holm AF, Rijntjes E, Mulder PG, Vroom TM. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990;93:66-72.
61. 61. Nelson RP Jr, Di Nicolo R, Fernandez-Caldas E, Seleznick MJ, Lockey RF, Good RA. Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects. J Allergy Clin Immunol 1996;98:258-263.
62. 62. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
63. 63. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999;353:196-200.
64. 64. Holt PG, Macaubas C, Cooper D, Nelson DJ, McWilliam AS. Th-1/Th-2 switch regulation in immune responses to inhaled antigens. Role of dendritic cells in the aetiology of allergic respiratory disease. Adv Exp Med Biol 1997;417:301-306.
65. 65. Bellini A, Vittori E, Marini M, Ackerman V, Mattoli S. Intraepithelial dendritic cells and selective activation of Th2-like lymphocytes in patients with atopic asthma. Chest 1993;103:997-1005.
66. 66. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998;160:4090-4097.
67. 67. Nelson DJ, Holt PG. Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals. J Immunol 1995;155:3517-3524.
68. 68. Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p 1. Am J Respir Cell Mol Biol 1995;12:369-378.
69. 69. Mori L, Kleimberg J, Mancini C, Bellini A, Marini M, Mattoli S. Bronchial epithelial cells of atopic patients with asthma lack the ability to inactivate allergens. Biochem Biophys Res Commun 1995;217:817-824.
70. 70. Youn J, Chen J, Goenka S, et al. In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway disease. J Exp Med 1998;188:1803-1816.
71. 71. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DY. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998;101:96-102.
72. 71. van den Heuvel MM, Vanhee DD, Postmus PE, Hoefsmit EC, Beelen RH. Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol 1998;101:90-95.
73. 73. Bieber T. [Role of Langerhans cells in the physiopathology of atopic dermatitis] [Place des cellules de Langerhans dans la physiopathologic de la dermatitc atopique]. Pathol Biol (Paris) 1995;43:871-875.
74. 74. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-18; quiz 319.
75. 75. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154:1956-1963.
76. 76. Jung K, Imhof BA, Linse R, Wollina U, Neumann C. Adhesion molecules in atopic dermatitis: upregulation of alpha 6 integrin expression in spontaneous lesional skin as well as in atopen, antigen and irritative induced patch test reactions. Int Arch Allergy Immunol 1997;113:495-504.
77. 77. Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-361.
78. 78. Moller GM, Overbeek SE, van Helden-Meeuwsen CG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996;26:517-524.
79. 79. Holt PG, Thomas JA. Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997;91:145-150.
80. 80. Bieber T. Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. J Allergy Clin Immunol 1998;102:555-557.
81. 81. Katoh N, Bieber T. The high-affinity IgE receptor (Fc, RI) mediates prevention of apoptosis in human monocytes. 1999 (in press).
82. 82. Bieber T. The skin as target for immunoallergic reactions. In: Zierhut M, Thiel HJ, editors. Immunology of the skin and the eye. Buren, The Netherlands: Aelus Press, 1999:79-83.
83. 83. Stingl G, Gazze-Stingl LA, Aberer W, Wolff K. Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 1981;127:1707-1713.
84. 84. Denfeld RW, Tesmann JP, Dittmar H, et al. Further characterization of UVB radiation effects on Langerhans cells: altered expression of the costimulatory molecules B7-1 and B7-2. Photochem Photobiol 1998;67:554-560.
85. 85. Tang A, Udey MC. Effects of ultraviolet radiation on murine epidermal Langerhans cells: doses of ultraviolet radiation that modulate ICAM-1 (CD54) expression and inhibit Langerhans cell function cause delayed cytotoxicity in vitro. J Invest Dermatol 1992;99:83-89.
86. 86. Bacci S, Nakamura T, Streilein JW. Failed antigen presentation after UVB radiation correlates with modifications of Langerhans cell cytoskeleton. J Invest Dermatol 1996;107:838-843.
87. 87. Lappin MB, Wetss JM, Schopf E, Norval M, Simon JC. Physiologic doses of urocanic acid do not alter the allostimulatory function or the development of murine dendritic cells in vitro. Photodermatol Photoimmunol Photomed 1997;13:163-168.
88. 88. Bhardwaj RS, Schwarz A, Becher E, et al. Proopiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996;156:2517-2521.
89. 89. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-332.